Castleark Management LLC Ligand Pharmaceuticals Inc Transaction History

Castleark Management LLC

$2.41 Billion
Q3 2024

A detailed history of Castleark Management LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Castleark Management LLC holds 67,923 shares of LGND stock, worth $8.33 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

67,923

Previous 61,363 10.69%

Holding current value

$8.33 Million

Previous $5.17 Million 31.59%

% of portfolio

0.28%

Previous 0.21%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$82.7 - $110.11 $542,512 - $722,321	6,560 Added 10.69%	67,923 $6.8 Million
Q2 2024 Aug 13, 2024	SELL	$68.53 - $87.91 $37,691 - $48,350	-550 Reduced 0.89%	61,363 $5.17 Million
Q1 2024 May 15, 2024	SELL	$68.64 - $89.2 $54,156 - $70,378	-789 Reduced 1.26%	61,913 $4.53 Million
Q4 2023 Feb 14, 2024	BUY	$49.57 - $72.63 $1.17 Million - $1.71 Million	23,520 Added 60.03%	62,702 $4.48 Million
Q3 2023 Nov 15, 2023	SELL	$58.86 - $72.67 $48,265 - $59,589	-820 Reduced 2.05%	39,182 $2.35 Million
Q2 2023 Aug 15, 2023	BUY	$69.53 - $79.33 $2.78 Million - $3.17 Million	40,002 New	40,002 $2.88 Million
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $2.16 Million - $3.06 Million	-24,115 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $1.65 Million - $2.98 Million	24,115 New	24,115 $2.7 Million
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $4.21 Million - $5.67 Million	-39,775 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$128.36 - $272.13 $5.39 Million - $11.4 Million	-42,025 Reduced 51.38%	39,775 $5.4 Million
Q3 2018 Nov 15, 2018	SELL	$211.18 - $274.49 $2.2 Million - $2.86 Million	-10,415 Reduced 11.29%	81,800 $22.5 Million
Q2 2018 Aug 15, 2018	BUY	$150.77 - $207.98 $1.27 Million - $1.76 Million	8,439 Added 10.07%	92,215 $19.1 Million
Q1 2018 May 15, 2018	SELL	$138.63 - $182.62 $2.3 Million - $3.02 Million	-16,564 Reduced 16.51%	83,776 $13.8 Million
Q4 2017 Feb 15, 2018	SELL	$128.36 - $147.04 $1,283 - $1,470	-10 Reduced 0.01%	100,340 $13.7 Million
Q3 2017 Nov 15, 2017	BUY	$120.91 - $137.94 $12.1 Million - $13.8 Million	100,350	100,350 $13.7 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Account

Castleark Management LLC Ligand Pharmaceuticals Inc Transaction History